Harnessing oncolytic virus-mediated immunity

Oncolytic viruses (OVs) have emerged as a promising anticancer treatment. OVs selectively infect, replicate in, and kill tumor cells. Oncolytic viral therapy occurs in two phases: an initial phase where the virus mediates direct oncolysis of tumor cells, and a second phase where an induced post-onco...

Descripción completa

Detalles Bibliográficos

Autores principales:	Volker Schirrmacher, Philippe Fournier
Formato:	Online
Lenguaje:	inglés
Publicado:	Frontiers Media SA 2021
Materias:	R5-920 RC581-607 RC254-282 anti-tumor activity immunovirotherapy oncolytic virus oncolytic virotherapy tumor-associated antigen immunotherapeutic approaches anti-viral response thema EDItEUR::M Medicine and Nursing
Acceso en línea:	18596
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!